Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Debt / NOTE 4.500% 7/1
-
Market price (% of par)
-
96.0%
-
Total 13F principal
-
$26,000
-
Principal change
-
-$25,000
-
Total reported market value
-
$24,000
-
Number of holders
-
2
-
Value change
-
-$23,000
-
Number of sells
-
1
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q2 2020
As of 30 Jun 2020 MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 had 2 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $26,000 principal (par value or face value) of the bond of the company.
Largest 2 bondholders included WELLS FARGO & COMPANY/MN and UBS Group AG.
This table shows 2 bond principal holders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.